Moderna, Inc.

Passed

Class Action Period:
January 18, 2023 - June 25, 2024

Lead Plaintiff Deadline:
October 08, 2024

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.

First Name

Last Name

Phone

Street Address

City

State

Zip

Shares Purchased

Purchase Date

Estimated Loss

The submission of this form does not create an attorney-client relationship.

Allegations

The filed complaint alleges that Moderna, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) mRNA-1345, an respiratory syncytial virus vaccine, was less effective than defendants had led investors to believe; (ii) accordingly, mRNA-1345’s clinical and/or commercial prospects were overstated; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Moderna purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Moderna during the relevant time frame, you have until October 08, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.